1833.HK

Ping An Healthcare and Technology Company Limited 1833.HK

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 1833.HK 1548.HK 2696.HK 1513.HK 6821.HK 0867.HK 2228.HK 1877.HK 3320.HK 2096.HK
6M 127.82 % 54.04 % 115.02 % 26.65 % 112.88 % 82.04 % 145.01 % 87.22 % -2.46 % 71.93 %
YTD 162.70 % 62.97 % 210.64 % 21.94 % 83.32 % 80.32 % 99.31 % 138.04 % -13.79 % 92.54 %
1Y 32.43 % 35.76 % 225.89 % 16.93 % 63.40 % 57.23 % 23.03 % 85.65 % -19.08 % 101.68 %
3Y 7.97 % -12.55 % 461.54 % 54.43 % 3.15 % 46.39 % 98.97 % 11.08 % -16.37 % 38.34 %
5Y -84.16 % 37.63 % 69.77 % -10.55 % -65.28 % 55.94 % 1 823.33 % -47.36 % 21.17 % 19.95 %
10Y -70.57 % 1 113.64 % 47.62 % 79.79 % -65.28 % 26.23 % 886.32 % 12.25 % -47.28 % 19.95 %
From the beginning -70.57 % 1 113.64 % 47.62 % 83.31 % -65.28 % 344.52 % 1 366.95 % 12.25 % -47.28 % 19.95 %

Dividend

Ping An Healthcare and Technology Company Limited

Genscript Biotech Corporation

Livzon Pharmaceutical Group Inc.

Asymchem Laboratories (Tianjin) Co., Ltd.

China Medical System Holdings Limited

XtalPi Holdings Ltd

China Resources Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited